-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Compared with placebo-treated participants, patients with active psoriatic arthritis and imaging-proven sacroiliitis who received guselkumab every 4 or 8 weeks had a greater average improvement in BASDAI and ASDAS ( As early as the 8th week), and continued to improve in the 52nd week .
PJ Mease, PS Helliwell, DD Gladman, D.
Leave a message here